CHF10067 intermediate dose

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	1

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05513950 (ClinicalTrials.gov)	January 25, 2023	17/8/2022	A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) i ...	A Phase Ib, Randomised, Double-blind, Placebo-controlled Study to Investigate the Safety, Tolerabili ...	Idiopathic Pulmonary Fibrosis	Biological: CHF10067 starting dose;Biological: CHF10067 intermediate dose;Biological: CHF10067 high ...	Chiesi Farmaceutici S.p.A.	NULL	Recruiting	40 Years	80 Years	All	24	Phase 1	United Kingdom

First Previous1Next Last